SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-20-028904
Filing Date
2020-10-21
Accepted
2020-10-21 16:56:46
Documents
1
Period of Report
2020-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4185
  Complete submission text file 0000899243-20-028904.txt   5550
Mailing Address C/O ALEXION PHARMACEUTICALS, INC 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Hallal David (Reporting) CIK: 0001457477 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39401 | Film No.: 201250977

Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Issuer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)